American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Here’s why the CVS Health stock price may rebound in 2025

by admin December 11, 2024
December 11, 2024
Here’s why the CVS Health stock price may rebound in 2025

CVS Health stock price continued to underperform the market this year as the pharmacy industry faced significant challenges. It has dropped by over 30% this year, while the S&P 500 and Nasdaq 100 indices have soared to a record high. 

Pharmaceutical retailers are in a crisis

CVS Health and other companies in the industry are in a crisis mode as growth slows, costs rise, and competition escalates.

Rite Aid, one of the biggest players in the industry, has already filed for bankruptcy, while Walgreens Boots Alliance has been kicked out of the Dow Jones index. Media reports suggest that the company may be taken private soon.

CVS Health Group is also not doing well. It recently concluded its restructuring, and the company has hinted that it may change its business strategy soon.

One of the things being considered is spinning off its Aetna business, which it acquired for $69 billion in 2018. Such a spin-off would give Aetna a smaller valuation since the combined company is now valued at $70 billion.

CVS is facing major challenges. Wages in its shops have risen in the past few years as many states have been forced to add salaries. At the same time, the company is struggling with retail theft and has been forced to lock up some products, a solution that has pushed more customers away. 

Further, CVS and Walgreens were forced to pay over $10 billion to settle opioid claims, with the former agreeing to pay $5.7 billion over 10 years. 

The company is also facing strong competition from companies like Amazon and Walmart, which have spent billions investing in the pharmaceutical industry. 

More customers are using these retailers to do their shopping, partly because of their subscription packages like Walmart+ and Amazon Prime.

Read more: Why CVS Health stock could appreciate 35% from here

Good top-line growth, but weak  bottom-line momentum

CVS Health are seeing weak top-line and bottom-line growth. The most recent financial results showed that its top-line growth did well. Its total revenue rose to $95 billion in the last quarter from $89 billion in the same period last year.

CVS Health’s nine-month revenue rose to over $275 billion from the previous $263 billion. Most of this revenue growth was because of its premiums, which rose to over $30 billionn, and services, which rose to $4.27 billion.

CVS reported a net income of just $87 million, a big drop from the $2.26 billion it made last year. This significant decline was partly because of the $1.1 billion restructuring costs that it spent. Assuming that it had not these restructuring costs, its net income would have been much lower than last year.

Analysts expect that CVS Health’s revenue rose by 3.53% to $97.1 billion in the current quarter. Its annual revenue this year will be $371 billion, followed by $386 billion in the next financial year.

CVS Health’s earnings per share is set to drop to $5.31 this year from $8.74 last year. The profitability will then recover to $6.38 next year. This performance, coupled with its planned restructuring means that the stock will bounce back. It has also replaced the former CEO Karen Lynch with David Joyner.

CVS Health stock price analysis

CVS chart by TradingView

The daily chart shows that the CVS share price has been in a strong bearish trend. It has found a strong support at $53.76, where it has failed to move below several times since June this year.

There are signs that CVS has formed a triple-bottom pattern, a popular bullish sign in the market. The 50-day and 100-day Exponential Moving Averages (EMA) have remained above the price.

Therefore, a contrarian case for the CVS Health stock price can be made. If this happens, the next point to watch will be at $66.92, the triple-bottom’s neckline, which is about 21.5% above the current level.

The post Here’s why the CVS Health stock price may rebound in 2025 appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Alphabet jumps the most since October on Willow quantum chip breakthrough
next post
Dow and S&P 500 flat as markets await US inflation data; Alaska Air Group shares jump, while NVIDIA and Oracle slip

Related Posts

Costco stock could have more surprises in store...

September 28, 2024

China’s November factory growth surges to 5-month high:...

December 2, 2024

Reddit stock price has imploded: is it safe...

March 11, 2025

Will Nvidia, and other AI stocks continue dream...

January 2, 2025

Brigitte Macron wins defamation lawsuit against conspiracy theorists...

September 13, 2024

Taylor Swift endorses Kamala Harris: Can the singer’s...

September 11, 2024

US tariffs trigger layoffs in Canadian steel and...

March 26, 2025

‘Bitcoin-style encryption’ for XChat? Musk’s claim sparks debate

June 2, 2025

Hang Seng, China’s CSI 300 slip after US...

January 7, 2025

Josh Brown questions Nike’s ability to turn around,...

May 30, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Interview: Strategic location gives Brazil Potash cost advantage in domestic fertiliser market, says CEO Matt Simpson

      June 1, 2025
    • Canada’s Q1 GDP expands by 2.2%, driven by exports spike ahead of potential US tariffs

      June 1, 2025
    • President Trump to host farewell for Elon Musk as DOGE leader steps away

      June 1, 2025
    • UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

      June 1, 2025
    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025

    Categories

    • Business (3,012)
    • Investing (2,455)
    • Latest News (1,994)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved